Chemed Co. (NYSE:CHE) CEO Sells $1,187,340.00 in Stock

Chemed Co. (NYSE:CHE) CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total value of $1,187,340.00. Following the completion of the transaction, the chief executive officer now directly owns 102,679 shares in the company, valued at approximately $60,957,441.93. This represents a 1.91 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.

Chemed Price Performance

Shares of NYSE:CHE opened at $595.86 on Monday. The company has a market capitalization of $8.72 billion, a P/E ratio of 30.11, a P/E/G ratio of 2.15 and a beta of 0.43. Chemed Co. has a 1-year low of $512.12 and a 1-year high of $654.62. The firm’s 50 day simple moving average is $553.87 and its two-hundred day simple moving average is $563.91.

Chemed Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Monday, February 24th will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.34%. The ex-dividend date of this dividend is Monday, February 24th. Chemed’s dividend payout ratio is currently 10.05%.

Institutional Investors Weigh In On Chemed

A number of institutional investors and hedge funds have recently bought and sold shares of the business. HighTower Advisors LLC grew its position in shares of Chemed by 78.0% during the third quarter. HighTower Advisors LLC now owns 3,730 shares of the company’s stock worth $2,246,000 after purchasing an additional 1,634 shares in the last quarter. XTX Topco Ltd boosted its stake in Chemed by 111.5% in the 3rd quarter. XTX Topco Ltd now owns 2,843 shares of the company’s stock worth $1,709,000 after purchasing an additional 1,499 shares during the period. Geode Capital Management LLC grew its holdings in Chemed by 4.9% during the 3rd quarter. Geode Capital Management LLC now owns 335,443 shares of the company’s stock valued at $201,820,000 after buying an additional 15,791 shares in the last quarter. Signal Advisors Wealth LLC raised its position in shares of Chemed by 60.7% during the fourth quarter. Signal Advisors Wealth LLC now owns 4,995 shares of the company’s stock valued at $2,647,000 after buying an additional 1,886 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of Chemed by 8.1% in the third quarter. Charles Schwab Investment Management Inc. now owns 122,788 shares of the company’s stock worth $73,792,000 after buying an additional 9,178 shares in the last quarter. 95.85% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a research report on Friday.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.